| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/19/2009 | US7534931 Preparing transgenic potato with altered starch synthase activity for improving quality of plant foodstuff, paper, textile or adhesives |
| 05/19/2009 | US7534930 cell comprising an endochitinase, a stilbene synthase and a superoxide dismutase; encoded from a nucleic acid construct which comprises an internal ribosome entry site sequence; confer resistance to sigatoka |
| 05/19/2009 | US7534929 Avians expressing heterologous protein |
| 05/19/2009 | US7534879 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing |
| 05/19/2009 | US7534878 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 05/19/2009 | US7534877 Non-M, non-O HIV-1 strains, fragments and uses |
| 05/19/2009 | US7534876 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/19/2009 | US7534874 Gene involved in V(D)J recombination and/or DNA repair |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534865 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534864 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534863 Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins |
| 05/19/2009 | US7534861 Compositions and methods for immunoaffinity purification |
| 05/19/2009 | US7534859 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 05/19/2009 | US7534856 PRO19624 antibodies |
| 05/19/2009 | US7534774 Contacting a wound site with formulation comprising nucleic acid molecule and a biocompatible matrix, the wound site being situated in a tissue associated with the fluid space |
| 05/19/2009 | US7534773 reduces the expression of testosterone-repressed prostate message-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer; Combined use with taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer |
| 05/19/2009 | US7534742 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states, comparing |
| 05/19/2009 | US7534621 Method of producing probe medium and method of immobilizing probe using probe medium |
| 05/19/2009 | US7534614 Isolating nucleic acid encoding a plant polypeptide for use in generating disease resistant plants; obtain library, incubate with probe, recover clone, transform plant, propagate, evaluate for disease resistance |
| 05/19/2009 | US7534613 Methods of treating parkinson's disease using viral vectors |
| 05/19/2009 | US7534602 Promoters and usage thereof |
| 05/19/2009 | US7534598 surface of a cell is irradiated with laser beam to make an opening in the cell membrane, and a drug fluid is inserted in the cell through the opening |
| 05/19/2009 | US7534597 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production |
| 05/19/2009 | US7534594 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/19/2009 | US7534592 Crystallization of carboxyltransferase domain of Acetyl-CoEnzyme A Carboxylase 2 with a ligand |
| 05/19/2009 | US7534585 Multifunctional cytokines |
| 05/19/2009 | US7534580 Invention identifies carrier protein to which PSP94 is bound (named PSP94-binding protein), its nucleic acid and amino acid sequences; use in diagnosis and prognosis of PSP94 related disease |
| 05/19/2009 | US7534577 Functional assays that use the T1R2 taste receptor to identify potential taste modulators |
| 05/19/2009 | US7534575 Method for detecting cancer using an antibody to Zcytor16 |
| 05/19/2009 | US7534570 Method for the detection of cytosine methylations in immobilized DNA samples |
| 05/19/2009 | US7534566 Nucleic acid labeling method and liquid composition |
| 05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
| 05/19/2009 | US7534561 Nucleic acid array in situ fabrication methods and arrays produced using the same |
| 05/19/2009 | US7534559 Feline polynucleotide vaccine formula |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | US7534439 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 05/19/2009 | US7534437 new mutant forms of the Sm14 protein, for producing a greater production volume; providing protection against schistosome and fasciola infection |
| 05/19/2009 | US7534436 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534425 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 05/19/2009 | US7534424 Optimizing the dosage of a therapeutic nucleic acid by using doxorubicin which is known to deplete liver macrophages known as Kupffer cells, thereby reducing liver toxicity |
| 05/19/2009 | US7534331 Use of microfluidic systems in the electrochemical detection of target analytes |
| 05/19/2009 | CA2495529C Noonan syndrome gene |
| 05/19/2009 | CA2458872C Human ubiquitin-conjugating enzyme |
| 05/19/2009 | CA2428532C Lysate clearance and nucleic acid isolation using silanized silica matrices |
| 05/19/2009 | CA2402745C Improved microarray spotting instruments incorporating sensors and methods of using sensors for improving performance of microarray spotting instruments |
| 05/19/2009 | CA2400966C Rat model with the onset of prostate cancer |
| 05/19/2009 | CA2367955C Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/19/2009 | CA2345024C Modified tgf-.beta. superfamily proteins |
| 05/19/2009 | CA2318029C Apo-2 ligand |
| 05/19/2009 | CA2284111C Process for production of l-methionine .gamma.-lyase crystals |
| 05/19/2009 | CA2274620C Microfabricated sleeve devices for chemical reactions |
| 05/19/2009 | CA2247071C Dna vaccination for induction of suppressive t cell response |
| 05/19/2009 | CA2239490C Preparation of a multicombinatorial library of antibody gene expression vectors |
| 05/19/2009 | CA2230511C Flowering genes |
| 05/19/2009 | CA2224130C Nicotianamine aminotransferase and gene therefor |
| 05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 05/19/2009 | CA2032203C Amplification capture assay |
| 05/14/2009 | WO2009062195A2 Fusion proteins of mannose binding lectins for treatment of disease |
| 05/14/2009 | WO2009062157A1 Epigenetic modification of cell phenotype, fate and/or function by rna transfer |
| 05/14/2009 | WO2009062149A1 Methods for maintaining inner ear neurons |
| 05/14/2009 | WO2009062122A1 Utility of ret mutant in diagnosis and treatment of melanoma |
| 05/14/2009 | WO2009062050A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 05/14/2009 | WO2009061950A2 Endophytic fungi from pteromischum sp. plant, compounds and methods of use |
| 05/14/2009 | WO2009061853A2 Mutant interleukin-2 (il-2) polypeptides |
| 05/14/2009 | WO2009061852A2 Modulation of factor 9 expression |
| 05/14/2009 | WO2009061851A2 Modulation of factor 7 expression |
| 05/14/2009 | WO2009061841A2 Modified polynucleotides as antidotes to antisense compounds |
| 05/14/2009 | WO2009061840A1 Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation |
| 05/14/2009 | WO2009061776A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt2 polypeptides and homologs thereof |
| 05/14/2009 | WO2009061720A1 Methods for increasing starch content in plants |
| 05/14/2009 | WO2009061442A1 Method to produce induced pluripotent stem (ips) cells form non-embryonic human cells |
| 05/14/2009 | WO2009061429A2 Global transcription machinery engineering targeting the rnap alpha subunit (rpoa) |
| 05/14/2009 | WO2009061422A1 Tobacco cultivar aob 175 and products therefrom |
| 05/14/2009 | WO2009061421A1 Tobacco cultivar aob 176 and products therefrom |
| 05/14/2009 | WO2009061413A2 Hybrid fusion reporter and uses thereof |
| 05/14/2009 | WO2009061382A2 Cardiac stem cell and myocyte secreted paracrine factors and uses thereof |
| 05/14/2009 | WO2009061380A2 VARIANTS OF BACILLUS sup. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
| 05/14/2009 | WO2009061379A2 Alpha-amylase variants with altered properties |
| 05/14/2009 | WO2009061378A2 Variants of bacillus licheniformis alpha-amylase with increased thermostability and/or decreased calcium dependence |
| 05/14/2009 | WO2009061369A2 Directed evolution using proteins comprising unnatural amino acids |
| 05/14/2009 | WO2009061216A1 Compositions and methods for altering the production of pigment in plants |
| 05/14/2009 | WO2009061215A1 Compositions and methods for altering pigment production in plants |
| 05/14/2009 | WO2009061214A1 Compositions and methods for modulating pigment production in plants |
| 05/14/2009 | WO2009061130A2 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 05/14/2009 | WO2009061003A2 Nucleic acid complex and nucleic acid delivery composition |
| 05/14/2009 | WO2009060982A1 Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent |
| 05/14/2009 | WO2009060963A1 Process for production of 4-hydroxyisoleucine or 2-amino-3-methyl-4-ketopentanoic acid |
| 05/14/2009 | WO2009060961A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | WO2009060857A1 Method for producing membrane protein |
| 05/14/2009 | WO2009060847A1 Method and kit for preparation of sample for use in nucleic acid amplification |
| 05/14/2009 | WO2009060804A1 Mutant nucleic acid associated with chronic myeloproliferative disorder, and method for evaluation of chronic myeloproliferative disorder |
| 05/14/2009 | WO2009060710A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same |
| 05/14/2009 | WO2009060455A1 Polyploid castor plants, compositions derived therefrom and uses of same |
| 05/14/2009 | WO2009060429A2 Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| 05/14/2009 | WO2009060402A2 Plant promoters of the xvsap1 gene |
| 05/14/2009 | WO2009060316A2 Hepatitis b virus-binding polypeptides and methods of use thereof |